Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Amit Hazan - Head of Corporate Finance & Banking Relations - Teva Pharmaceuticals | LinkedIn
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote - YouTube
Teva Pharmaceutical S&P rating outlook changed to stable | Seeking Alpha
Teva Announces New Org Structure, Leadership Changes | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Teva Announces Appointment of New Chief Financial Officer | BioSpace
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance